Here are five things to know:
1. The company will introduce GELSYN-3, CellXtract and SIGNAFUSE Bioactive Bonegraft Putty at the meeting.
2. The GELSYN-3 is a three-injection, hyaluronic acid-based product for pain relief from knee osteoarthritis.
3. CellXtract is a novel cell and bone marrow extraction tool.
4. SIGNAFUSE Bioactive Bonegraft Putty is a graft comprised of a bi-phasic mineral composite combined with a patented bioactive glass and resorbable polymer carrier.
5. Bioventus is an orthobiologics company with two product portfolios — Bioventus Active Healing Therapies and Bioventus Surgical.
More articles on devices:
Medical Compression Systems unveils ActiveCare platform at AAOS meeting — 4 takeaways
Medacta showcases latest surgical innovations at AAOS meeting — 5 takeaways
EOS imaging’s spineEOS receives CE Mark: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
